544205 — National Peroxide Cashflow Statement
0.000.00%
- IN₹3.71bn
- IN₹3.27bn
- IN₹2.87bn
- 44
- 36
- 31
- 28
Annual cashflow statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Net Income/Starting Line | 535 | 215 | -20.8 |
Depreciation | |||
Non-Cash Items | 32 | -13.2 | -14.1 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -93.9 | -30.5 | 20.5 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 671 | 364 | 187 |
Capital Expenditures | -59.9 | -146 | -48.9 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 308 | -28.8 | 31.6 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Change in Net Investments | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 248 | -175 | -17.3 |
Financing Cash Flow Items | -63 | -27.1 | -15.9 |
Other Financing Cash Flow | |||
Total Cash Dividends Paid | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | -860 | -167 | -125 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 59.3 | 21.8 | 43.2 |